NCT04838288View on ClinicalTrials.gov

Cognitive Outcomes in Stable Renal Transplant Patients Switched FromTacrolimus to Envarsus XR™

PHASE4Active, not recruitingINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

June 22, 2021

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions

Renal Transplant

Interventions

DRUG

Change from Prograf to Envarsus XR

Change from Tacrolimus taken twice a day to Envarsus XR taken once a day

Trial Locations (1)

37232

VUMC, Nashville

Sponsors

Collaborators (1)

Veloxis Pharmaceuticals

All Listed Sponsors

collaborator

Veloxis Pharmaceuticals

INDUSTRY

lead

Vanderbilt University Medical Center

OTHER